Elysian Capital’s £103 Million Sale Of Wellbeing Software To The Citadel Group

Stephenson Harwood LLP has advised Elysian Capital on this deal, and Gadens advised Citadel Group.

The sale of Wellbeing represents the sixth exit from Elysian Capital I LP and realises a 4.5x return for the fund. Wellbeing is one of the UK’s major healthcare software companies. Over its history of more than 25 years, Wellbeing has grown through a combination of organic development and acquisitions into a leading UK provider of radiology and maternity healthcare software. Wellbeing is aligned to the UK National Health Service’s long-term care agenda, with one or more of its solutions being used in 81% of NHS Trusts across England.

The Citadel Group is a company listed on The Australian Stock Exchange.

The Stephenson Harwood team was led by private equity partner Malcolm MacDougall (Picture), with support from senior associates Chris Manning and Nicola Baird, and associate Dafni Loizou.

The Gadens team was led by Corporate partner Jeremy Smith and senior associate Steven Wambeek led the transaction, with support from Matthew Trinca, Yoni Baker and Brittany Kluske.

Involved fees earner: Yoni Baker – Gadens; Brittany Kluske – Gadens; Jeremy Smith – Gadens; Matthew Trinca – Gadens; Steven Wambeek – Gadens; Dafni Loizou – Stephenson Harwood; Malcolm MacDougall – Stephenson Harwood; Chris Manning – Stephenson Harwood;

Law Firms: Gadens; Stephenson Harwood;

Clients: Citadel Group ; Elysian Capital;